Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 4, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 4, 2016View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 2, 2016View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventApr 28, 2016View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 25, 2016View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveApr 25, 2016View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderApr 18, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 16, 2016View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KMar 15, 2016View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-136

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information